Reuters logo
15 天前
BRIEF-Trovagene engages PRA Health Sciences to conduct phase 1b/2 trial of PCM-075
2017年7月6日 / 中午12点13分 / 15 天前

BRIEF-Trovagene engages PRA Health Sciences to conduct phase 1b/2 trial of PCM-075

1 分钟阅读

July 6 (Reuters) - Trovagene Inc

* Trovagene engages leading cro in aml to conduct phase 1b/2 trial of pcm-075 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below